Neogen Corporation NEOG
$ 15.0
2.85%
Quarterly report 2024-Q3
added 10-10-2024
Country |
USA |
IPO year |
1989 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. John Adent |
Employees in the company |
1 764 |
Shares |
216 M |
Market Cap[1] |
$ 3.25 B |
EBITDA (LTM) |
$ 154 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.